Puramed Bioscience Inc. Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five
Puramed Bioscience Inc. had Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five of $6.70 thousand as of 2014-06-30, per its 10-K filed 2014-10-14.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Rolling Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive · last filed 2014-10-14
- 2014-06-30: Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five $6.70K.
- 2013-06-30: Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five $5.86K.
| Period end | Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five |
|---|---|
| 2014-06-30 | $6.70K 10-K · filed 2014-10-14 |
| 2013-06-30 | $5.86K 10-K · filed 2013-10-15 |